These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 10752001

  • 1. Are SSRIs safe for pregnant and breastfeeding women?
    Misri S, Burgmann A, Kostaras D.
    Can Fam Physician; 2000 Mar; 46():626-8, 631-3. PubMed ID: 10752001
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [Abstract] [Full Text] [Related]

  • 3. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
    Sie SD, Wennink JM, van Driel JJ, te Winkel AG, Boer K, Casteelen G, van Weissenbruch MM.
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
    [Abstract] [Full Text] [Related]

  • 4. [The safety profile of escitalopram in pregnancy and breastfeeding].
    Bellantuono C, Orsolini L, Bozzi F.
    Riv Psichiatr; 2013 Nov; 48(6):407-14. PubMed ID: 24441517
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
    Bakker MK, Kölling P, van den Berg PB, de Walle HE, de Jong van den Berg LT.
    Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
    [Abstract] [Full Text] [Related]

  • 7. Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy.
    Ornoy A, Koren G.
    Semin Fetal Neonatal Med; 2014 Jun; 19(3):188-94. PubMed ID: 24321501
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety of selective serotonin reuptake inhibitors in pregnancy.
    Alwan S, Friedman JM.
    CNS Drugs; 2009 Jun; 23(6):493-509. PubMed ID: 19480468
    [Abstract] [Full Text] [Related]

  • 10. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.
    Cantor Sackett J, Weller RA, Weller EB.
    Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288
    [Abstract] [Full Text] [Related]

  • 11. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A.
    JAMA Psychiatry; 2016 Nov 01; 73(11):1163-1170. PubMed ID: 27732704
    [Abstract] [Full Text] [Related]

  • 12. The safety of newer antidepressants in pregnancy and breastfeeding.
    Gentile S.
    Drug Saf; 2005 Nov 01; 28(2):137-52. PubMed ID: 15691224
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies.
    Zhang TN, Gao SY, Shen ZQ, Li D, Liu CX, Lv HC, Zhang Y, Gong TT, Xu X, Ji C, Wu QJ.
    Sci Rep; 2017 Feb 21; 7():43085. PubMed ID: 28220881
    [Abstract] [Full Text] [Related]

  • 16. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
    Orsolini L, Bellantuono C.
    Hum Psychopharmacol; 2015 Jan 21; 30(1):4-20. PubMed ID: 25572308
    [Abstract] [Full Text] [Related]

  • 17. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.
    Grigoriadis S, Vonderporten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Ross LE.
    BMJ; 2014 Jan 14; 348():f6932. PubMed ID: 24429387
    [Abstract] [Full Text] [Related]

  • 18. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.
    Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R, HMO Research Network Center for Education, Research in Therapeutics.
    Pharmacoepidemiol Drug Saf; 2007 Oct 14; 16(10):1086-94. PubMed ID: 17729378
    [Abstract] [Full Text] [Related]

  • 19. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov 14; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.
    J Clin Psychiatry; 2004 Feb 14; 65(2):230-7. PubMed ID: 15003078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.